Markus Laube

32PUBLICATIONS
69CO-AUTHORS
Biologically active moleculesReaction engineering (excl. nuclear reactions)Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (32)

|Jun 12, 2026
An Approach Toward Radioiodination and Radiopharmacological Evaluation of a Carborane-Containing Analog of Indomethacin.

|May 13, 2026
Next-Gen 18F-Relay Reagent: Optimising [18F]Ethanesulfonyl Fluoride.

|Apr 01, 2026
Radioiodination of Two Carborane-Based Dual Cyclooxygenase-2/5-Lipoxygenase Inhibitors and Their In Vitro and In Vivo Evaluation.

Jonas Schädlich, Martin Ullrich, Cathleen Haase-Kohn

|Nov 27, 2025
In Vitro Characterization of the Published Glypican-3-Targeting Peptide TJ12P2 Reveals a Lack of Specificity and Potency.

Eva-Maria Burger, Charlice Hill, Robert Wodtke

|Nov 13, 2025
Novel Ruthenacarborane-NSAID Conjugates.

Sonam Sonam, Marija Mojić, Vuk Gordić

|Jul 30, 2025
PET and SPECT Tracer Development via Copper-Mediated Radiohalogenation of Divergent and Stable Aryl-Boronic Esters.

Austin Craig, Frederik J Sachse, Markus Laube

Pageof 6

Frequent Collaborators

29 joint publications

Jens Pietzsch

12 joint publications

Evamarie Hey-Hawkins

9 joint publications

Robert Wodtke

7 joint publications

Klaus Kopka